Birdwatch Archive

Birdwatch Note Rating

2024-12-30 15:07:26 UTC - NOT_HELPFUL

Rated by Participant: 121E88DD660749CBCF69052D9AC45B84028D715C1E94D9FA706A56D304892751
Participant Details

Original Note:

Vivek developed a drug for Alzheimer’s through a subsidiary of Roivant, Axovant. This drug failed, like most Alzheimer’s drugs. Vivek did not profit from it, choosing not to sell shares in Axovant before its collapse. Roivant also avoided such sales. Blatant lies in post. https://x.com/implisci/status/1697335207462883518

All Note Details

Original Tweet

All Information

  • noteId - 1873548470784610305
  • participantId -
  • raterParticipantId - 121E88DD660749CBCF69052D9AC45B84028D715C1E94D9FA706A56D304892751
  • createdAtMillis - 1735571246021
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - NOT_HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 0
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 0
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 0
  • helpfulImportantContext - 0
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 1
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 0
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 1873548470784610305121E88DD660749CBCF69052D9AC45B84028D715C1E94D9FA706A56D304892751